© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Transgenic models in cardiac arrhythmias: how close can we get to the bedside?
Molecular Cardiology Laboratories, IRCCS Fondazione S Maugeri, Via Ferrata 8, 27100 Pavia, PV, Italy
* Tel.: +39-382-592050; fax: +39-382-592094. cnapolitano@fsm.it
Received 30 November 2003; accepted 2 December 2003
| The first 10% of the full text of this article appears below. |
See article by Tian et al. [8] (pages 256–267) in this issue.
The exponential growth of studies exploring the molecular bases of arrhythmogenesis is one of the most relevant trends recently taking place in the area of cardiovascular pathophysiology. The starting point of this line of research was the discovery of the DNA coding abnormalities causing Mendelian diseases (such as the Long QT syndrome (LQTS), the Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia) that alter cardiac excitability and cause sudden cardiac death. This step constituted the inception of
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Thomas, M. J. Killeen, I. S. Gurung, P. Hakim, R. Balasubramaniam, C. A. Goddard, A. A. Grace, and C. L.-H. Huang Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5 J. Physiol., January 1, 2007; 578(1): 99 - 114. [Abstract] [Full Text] [PDF] |
||||
